(Q50676873)

English

Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).

scientific article published in November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100). (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

1 reference

based on heuristic

inferred from title

author name string

Anna Dyszkiewicz-Korpanty

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

Horatiu Olteanu

2

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

Eugene P Frenkel

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

Ravindra Sarode

4

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

18

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

7

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

491-496

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Identification of the platelet ADP receptor targeted by antithrombotic drugs

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270.

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Loading, pretreatment, and interindividual variability issues with clopidogrel dosing

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Determinants of the interindividual variability in response to antiplatelet drugs

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Individual variations of platelet inhibition after loading doses of clopidogrel

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Resistance to clopidogrel: a review of the evidence

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Clopidogrel resistance: a new chapter in a fast-moving story

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Effects of Statins on Platelet Inhibition by a High Loading Dose of Clopidogrel

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study.

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Variability in platelet responsiveness to clopidogrel among 544 individuals.

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Platelets, leukocytes, and coagulation.

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Use of whole blood platelet lumi-aggregometry to optimize anti-platelet therapy in patients with chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists--in vitro experience

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

PFA-100 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty?

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Monitoring of clopidogrel action: comparison of methods

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

1 reference

https://api.crossref.org/works/10.1080%2F09537100701280654

21 January 2018

Identifiers

10.1080/09537100701280654

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17852774

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50676873&oldid=1248351850"